Just had a quick look at p14 of the h1 report:
Anticipated newsflow for the next 12 months includes:
-Confirmation of R&D rate Sept
-Commencement of UBI's PT INR self test
-Clinical trails for new products
-Feasibility for molecular diagnostics
ALSO J&J will provide notice or not...................
This thing will finally start to move solidly in the right direction.
Just had a quick look at p14 of the h1 report: Anticipated...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.172M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| UBI (ASX) Chart |
Day chart unavailable